1 active not recruiting, 1 recruiting, 1 terminated. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Not applicable | 1 | Active not recruiting 1 |
Follow CD40 Ligand Deficiency: new trials by email Literature Review of CD40 Ligand Deficiency trials Research Report on CD40 Ligand Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD) Hematopoietic stem cell transplant (HSCT) - Common Variable Immunodeficiency (CVID), Primary Immune Regulatory Disorder | Phase 2 | Recruiting | Paul Szabolcs | 25 | 2026-05-04 | 2026-05-15 |
| Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer Cyclophosphamide, Fludarabine Phosphate, Laboratory Biomarker Analysis - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission | Phase 2 | Terminated | Roswell Park Cancer Institute | 31 | 2017-12-07 | 2025-07-04 |
| Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies Alemtuzumab 0.3 mg, Cyclophosphamide, Busulfan - SCID, Omenn's Syndrome | Not applicable | Active not recruiting | Masonic Cancer Center, University of Minnesota | 57 | 2012-09-04 | 2026-06-17 |
Granulomatous Disease, Chronic (3) · Common Variable Immunodeficiency (2) · Hyper-IgM Immunodeficiency Syndrome (2) · Immunologic Deficiency Syndromes (2) · Severe Combined Immunodeficiency (2) · Wiskott-Aldrich Syndrome (2) · Anemia, Aplastic (1) · Anemia, Diamond-Blackfan (1) · Anemia, Sickle Cell (1) · Chediak-Higashi Syndrome (1) · Congenital amegakaryocytic thrombocytopenia (1) · DiGeorge Syndrome (1) · Hemoglobinuria, Paroxysmal (1) · Histiocytosis, Langerhans-Cell (1) · Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome (1)
Blood Protein Disorders (3) · Chronic Disease (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Disease Attributes (3) · Genetic Diseases, Inborn (3) · Genetic Diseases, X-Linked (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Leukocyte Disorders (3) · Lymphatic Diseases (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3)
Cyclophosphamide (2) · Stem Cell Transplantation (2) · fludarabine phosphate (2) · Alemtuzumab (1) · Busulfan (1) · Melphalan (1) · Mesna (1) · Peripheral Blood Stem Cell Transplantation (1) · Sodium (1) · Whole-Body Irradiation (1)
Masonic Cancer Center, University of Minnesota (1) · Paul Szabolcs (1) · Roswell Park Cancer Institute (1)
United States (3)
Meera Srikanthan, MD (1) · Paul Szabolcs, MD (1) · Philip McCarthy, MD (1)